Copyright information:Taken from "Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients"BMC Cancer 2006;6():183-183.Published online 11 Jul 2006PMCID:PMC1539015. Cells were treated with SAHA or paclitaxel for 24 hours. Total protein (30 μg) was separated by a 15% polyacrylamid gel. Western blot analyses were performed with antibodies against acetylated histone H3.